The UK approves a new cream for excessive sweating, aiming to reduce symptoms for patients who struggle with the condition. Sources report that the treatment can cut sweating by up to 90%, and that it is expected to be available to thousands of NHS patients.
Both outlets describe the cream as the first of its kind approved for this use in the UK. The reports do not provide additional clinical details in the excerpts provided, such as the specific active ingredient, how it is administered, or the size and results of any supporting trials. They also do not specify eligibility criteria, prescribing timelines, or whether the product is limited to certain types of sweating.
